Cargando…
BACE1 activity regulates cell surface contactin-2 levels
BACKGROUND: Although BACE1 is a major therapeutic target for Alzheimer’s disease (AD), potential side effects of BACE1 inhibition are not well characterized. BACE1 cleaves over 60 putative substrates, however the majority of these cleavages have not been characterized. Here we investigated BACE1-med...
Autores principales: | Gautam, Vivek, D’Avanzo, Carla, Hebisch, Matthias, Kovacs, Dora M, Kim, Doo Yeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899608/ https://www.ncbi.nlm.nih.gov/pubmed/24405708 http://dx.doi.org/10.1186/1750-1326-9-4 |
Ejemplares similares
-
Synaptotagmins interact with APP and promote Aβ generation
por: Gautam, Vivek, et al.
Publicado: (2015) -
Identification of BACE1 cleavage sites in human voltage-gated sodium channel beta 2 subunit
por: Gersbacher, Manuel T, et al.
Publicado: (2010) -
Human Neurospheroid Arrays for In Vitro Studies of Alzheimer’s Disease
por: Jorfi, Mehdi, et al.
Publicado: (2018) -
No Evidence for Association of Autism with Rare Heterozygous Point
Mutations in Contactin-Associated Protein-Like 2 (CNTNAP2), or
in Other Contactin-Associated Proteins or Contactins
por: Murdoch, John D., et al.
Publicado: (2015) -
The Glycosylphosphatidyl Inositol-Anchored Adhesion Molecule F3/Contactin Is Required for Surface Transport of Paranodin/Contactin-Associated Protein (Caspr)
por: Faivre-Sarrailh, Catherine, et al.
Publicado: (2000)